Nikki Hafezi-Kristoffersen, MAS IP ETHZ, CEO of the ELZA Institute and executive at the MESCA Foundation, recently visited the Bukhara State Medical Institute (BSMI).
Dual chromophore PACK-CXL treatment using riboflavin/UV-A and rose bengal/green light may offer an effective solution for refractory Acanthamoeba keratitis.
“I actually heard about the ELZA Institute from my cigar dealer,” they laughed. “And Syfovre? I just Googled it and saw it was from America and very expensive.”
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
Visit ELZA Zurich HB, our modern eye clinic in Zurich Hauptbahnhof. Find us at Bahnhofplatz 15, 2nd floor, Ostrisalit – above The Counter.
Drooping Eyelids? From reimbursement criteria to tips for a quick recovery: Here you can find out what an ophthalmologist says you need to know about eyelid surgery.
Featured in the November/December 2024 issue of Glaucoma Today, an article by ELZA Consultant Surgeon Dr. Kaweh Mansouri highlights the Eyemate continuous intraocular pressure (IOP) monitoring implant.
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
Epi-On Cross-Linking goes office-based! ELZA’s innovation eliminates bulky equipment, offering streamlined keratoconus care, tells Farhad Hafezi to Ocular Surgery News.
During Swiss Days 2024 in Tashkent, the ELZA Institute’s CEO, Nikki L. Hafezi, led a keratoconus screening initiative that identified critical cases and strengthened Swiss-Uzbek collaborations. The event, featured on Zo’r TV, highlights ELZA’s global healthcare impact.
